Hundreds of hours of research, prototype development, and clinical testing have resulted in the creation of a progression of treatment devices that have increased in electronic complexity and clinical effectiveness over the past 12 years. Four major areas of focus:

1. Creation of Frequency Generators: Designing, prototyping and manufacturing a limited number of Frequency Specific Resonance Generators for clinical testing that is in compliance with FDA standards for Non Significant Risk (NSR) devices;
2. Creation of Software to Program Frequency Specific Resonance Generators: Designing and writing user friendly software to programs the prototype frequency generators.
3. Clinical Testing and Evaluation: Establish outpatient protocols to determine the clinical effectiveness and user acceptance of the prototype frequency generators.
4. Reviewing and compiling the published literature (both peer reviewed and non-peer reviewed) with reference to the basic science research and the clinical trials that involve magnetic, electric and electromagnetic fields.

   Starting with a basic two-channel PEMF generating device created in 2012, the Frequency Specific Resonance Frequency Generators have evolved to today’s multi-channel synchronized pulsed magnetic and pulsed electric field generators with the capacity of frequency modulation.

   In 2023, the Frequency Specific Clinical Incubator initiated the prototype and design of new technology to activate and stimulate human blood plasma by means of pulsed magetic, laser and plasma fields. Using the standard protocols developed for Platelet Rich Plasma Therapy (PRP), the combination pulsed 650 nm Class 2 lasers, low frequency pulsed magnetic fields and low frequency pulsed plasma fields was designed and prototyped to radiate human blood plasma sterily without altering the chemical composition of the plasma. Enclosure 2 outlines the prototyped treatment protocol for activating human blood plasma.